Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The British Journal of Psychiatry : the Journal of Mental Science|May 23, 2015
Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: randomised double-blind placebo-controlled trialLakshmi N Yatham, Eduard Vieta, Guy M Goodwin, et al.Clinical Drug Investigation|July 31, 2020
Agomelatine in Standard Medical Practice in Depressed Patients: Results of a 1-Year Multicentre Observational Study In FrancePhilip Gorwood, Jacques Benichou, Nicolas Moore, et al.Journal of Psychopharmacology (Oxford, England)|July 28, 2010
Agomelatine facilitates positive versus negative affective processing in healthy volunteer modelsCatherine J Harmer, Christian de Bodinat, Gerard R Dawson, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 17, 2017
Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled studyDan J Stein, Antti Ahokas, Marek Jarema, et al.Human Psychopharmacology|September 25, 2020
The safety of agomelatine in standard medical practice in depressed patients: A 26-week international multicentre cohort studyPhilip Gorwood, Jacques Benichou, Nicholas Moore, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 24, 2018
12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25-50 mg/day) versus escitalopram (10-20 mg/day) in out-patients with severe generalized anxiety disorderDan J Stein, Jon-Paul Khoo, Antti Ahokas, et al.Pageof 2